Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon

Authors

  • Henry C. Y. Wong
  • Fiona M. Y. Lim
  • Ashley C. K. Cheng

Abstract

Aortic thrombosis is a rare disease entity which has been reported to be related to malignancy and chemotherapeutic agents. Here we present the first case in literature about a colon cancer patient with well-controlled vascular risk factors who developed acute aortic thrombosis after the first cycle of adjuvant chemotherapy with capecitabine-oxaliplatin. Risk factors and causal relationship between systemic anti-cancer agents and this condition are reviewed and discussed.

Downloads

Published

2019-09-25

How to Cite

Wong, H. C. Y., Lim, F. M. Y., & Cheng, A. C. K. (2019). Acute Aortic Thrombosis Related to Adjuvant Capecitabine-Oxaliplatin in a Chinese Patient with Resected Adenocarcinoma of Sigmoid Colon. Archives of Clinical and Medical Case Reports, 3(5), 342–348. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22157